Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

Diverticulitis Disease Market Revenue Outlook: What CAGR Is Expected Through 2030?

The market encompassing diverticulitis treatments has experienced robust expansion lately, with projections indicating a substantial increase from $2.02 billion in 2025 to $2.21 billion in 2026, reflecting a compound annual growth rate of 9.0%. This prior period’s upward trajectory is linked to factors such as an expanding elderly demographic, dietary patterns characterized by insufficient fiber intake, challenges in achieving early disease detection, prevalent hospital-focused therapeutic approaches, and an increasing incidence of digestive system ailments.

The market for diverticulitis treatments is poised for substantial expansion over the upcoming years, projecting an increase to $3.22 billion by 2030, with a compound annual growth rate (CAGR) of 9.9%. This anticipated growth is fueled by several key factors, including heightened public awareness regarding digestive health and preventative measures, enhanced accessibility to advanced imaging technologies, a broader adoption of outpatient care settings, a decrease in invasive surgical procedures, and an increased emphasis on lifestyle adjustments. During this forecast period, significant trends are expected to shape the market, such as a rise in the diagnosis of less complex diverticulitis cases, a growing inclination towards non-surgical and outpatient management strategies, the expanded application of imaging for diagnosis, the increased utilization of antibiotics and supportive care, and greater consumer knowledge about managing the condition through diet and lifestyle.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12990&type=smp

#Diverticulitis Disease Market Growth Factors: Which Forces Are Supporting Market Expansion?

The escalating incidence of smoking addiction is poised to stimulate expansion within the diverticulitis disease market. This addiction signifies a compulsive reliance on nicotine products, encompassing cigarettes, e-cigarettes, and other tobacco items. Factors contributing to this surge include robust marketing efforts, greater societal acceptance, stress as a trigger, and the wider availability of vaping devices. The diverticulitis treatment sector benefits from this trend as smoking impairs blood circulation to the colon, heightening the risk and severity of diverticular conditions, consequently increasing the necessity for diagnosis and medical management. For example, data from the European Respiratory Society (ERS) in October 2024 indicated a substantial uptick in smoking among young individuals, with 40.1% of those surveyed in 2024 reporting smoking habits, a notable increase from the 22.5% recorded in 2022. Consequently, the growing prevalence of smoking addiction is anticipated to be a key driver for the diverticulitis disease market’s growth.

## Diverticulitis Disease Market Driver: Increasing Prevalence Of Diabetes Fuels Growth In The Market

The expanding occurrence of diabetes is projected to be a significant catalyst for the diverticulitis disease market’s advancement. Diabetes is a long-term metabolic condition marked by elevated blood sugar levels, stemming from insufficient insulin production or its ineffective use. This rising tide of diabetes is largely attributed to dietary habits dominated by processed foods, inactive lifestyles, increasing obesity rates, and an aging global population. The diverticulitis disease market aligns with this trend by offering solutions for diabetes-related complications, as elevated blood glucose levels can compromise blood vessels and make the colon more vulnerable to infections and inflammation, thereby boosting the need for diagnostic tools and treatments. Illustrating this, in June 2024, the National Health Service (NHS England) reported that the number of diagnosed pre-diabetes cases climbed to 3,615,330 in 2023, an 18% jump from the 3,065,825 cases in 2022, with a particularly sharp rise of nearly 25% in individuals under 40, increasing from 173,166 in 2022 to 216,440 in 2023. Therefore, the escalating prevalence of diabetes is fueling the expansion of the diverticulitis disease market.

Diverticulitis Disease Market Segmentation And Category Breakdown

The diverticulitis disease market covered in this report is segmented –

1) By Type: Uncomplicated, Complicated

2) By Diagnosis: Computed Tomography (Ct) Scan, Ultrasound, Urine Test, Blood Test

3) By Treatment: Medications, Surgery, Supportive Care, Penicillin Antibiotic, Antibiotics, Dietary Supplements, Intravenous (Iv) Fluids

4) By End-User: Specialty Centers, Hospitals, Research Centers

Subsegments:

1) By Uncomplicated: Outpatient Treatment, Dietary Management, Antibiotic Therapy

2) By Complicated: Hospitalization, Surgical Intervention, Intravenous Antibiotics, Abscess Drainage

Diverticulitis Disease Market Industry Trends: What Changes Are Reshaping Demand?

In the diverticulitis disease market, leading pharmaceutical firms are actively pursuing novel therapeutic agents and securing regulatory endorsements to solidify their market presence. This focus on drug discovery promises more efficacious interventions for diverticulitis, thereby mitigating complications and enhancing patient well-being. A notable advancement occurred in April 2023 when Seres’ innovative microbiota-based therapy, intended for recurrent intestinal infections, received approval from the U.S. Food and Drug Administration. This orally administered treatment, Vowst, is formulated to combat recurrent gut infections and prevent the relapse of Clostridioides difficile (C. diff.) in adult individuals 18 years and older. Its approval stemmed from a clinical investigation involving 346 participants suffering from recurrent CDI, which demonstrated a substantially reduced likelihood of infection recurrence among those administered Vowst compared to a placebo group. The drug’s efficacy is attributed to its composition of Firmicutes spores, recognized for their role in fostering a robust gut microbiome capable of impeding C. diff. colonization.

Diverticulitis Disease Market Competitive Analysis Of Major Industry Participants

Major companies operating in the diverticulitis disease market are Pfizer Inc., Johnson and Johnson, F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma, Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Company, Cipla Limited, Hikma Pharmaceuticals PLC, Endo Pharmaceuticals, Aspen Pharmacare, Zydus Lifesciences, Lupin Limited, Glenmark Pharmaceuticals, Alkem Laboratories, Torrent Pharmaceuticals Ltd.

Access The Complete Diverticulitis Disease Market Report:

https://www.thebusinessresearchcompany.com/report/diverticulitis-disease-global-market-report

Diverticulitis Disease Market Regional Analysis And Leading Geography

North Americawas the largest region in the diverticulitis disease market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the diverticulitis disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model